CTE logo

Cryosite Limited Stock Price

ASX:CTE Community·AU$43.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CTE Share Price Performance

AU$0.88
-0.04 (-4.35%)
AU$0.88
-0.04 (-4.35%)
Price AU$0.88

CTE Community Narratives

There are no narratives available yet.

Recent CTE News & Updates

Cryosite Limited's (ASX:CTE) Share Price Could Signal Some Risk

Aug 19
Cryosite Limited's (ASX:CTE) Share Price Could Signal Some Risk

Cryosite Limited's (ASX:CTE) Subdued P/E Might Signal An Opportunity

Jan 15
Cryosite Limited's (ASX:CTE) Subdued P/E Might Signal An Opportunity

Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02

Aug 22
Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02

Cryosite Limited Key Details

AU$14.1m

Revenue

AU$5.2m

Cost of Revenue

AU$8.9m

Gross Profit

AU$7.0m

Other Expenses

AU$1.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.039
Gross Margin
62.98%
Net Profit Margin
13.35%
Debt/Equity Ratio
0%

Cryosite Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with acceptable track record.

1 Risk
2 Rewards

About CTE

Founded
1999
Employees
25
CEO
n/a
WebsiteView website
www.cryosite.com

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Australian Market Performance

  • 7 Days: -0.2%
  • 3 Months: 5.3%
  • 1 Year: 8.9%
  • Year to Date: 9.5%
The market has stayed flat over the 7 days. More promisingly, the market is up 8.9% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›